novo nordisk lawsuit semaglutide sues spas and clinics for selling versions of Wegovy, Ozempic MintPrimer | As the patent

Putting Real-World Safety Signals Into Context GI side effects are the primary reason people stop GLP-1 therapy early, and the safety picture is not hypothetical

doi: 10.1007/978-981-13-1286-1_8

This can slow your metabolism and leave you weaker rather than healthier

(31 August 2025)

This physiological change sends strong, sustained signals of fullness to your brain for hours after a meal

Latest News AI-driven job fears are weighing on retirement confidence, especially among Gen Z and Millennials, Thrivent survey finds Its the second time in as many years regulators have penalized Centaurus Financial for lack of compliance with Reg BI